Target Price | $9.18 |
Price | $1.06 |
Potential |
766.04%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Brainstorm Cell Therapeutics Inc. 2026 .
The average Brainstorm Cell Therapeutics Inc. target price is $9.18.
This is
766.04%
register free of charge
$23.64
2,129.76%
register free of charge
$6.06
471.70%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend Brainstorm Cell Therapeutics Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Brainstorm Cell Therapeutics Inc. stock has an average upside potential 2026 of
766.04%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.31 | -1.59 |
61.44% | 31.17% | |
P/E | negative |
4 Analysts have issued a Brainstorm Cell Therapeutics Inc. forecast for earnings per share. The average Brainstorm Cell Therapeutics Inc. EPS is
This results in the following potential growth metrics and future valuations:
Brainstorm Cell Therapeutics Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.